Influence
April 10, 2020

Returning to normal in the post-pandemic world

Covid-19 is omnipresent. But what happens after conditions begin to improve? Regenstrief President and CEO Peter Embí, M.D., and VP for Data and Analytics Shaun Grannis, M.D., propose strategies for responsibly getting to the new normal of the post-pandemic world.

Their essay, “Here’s what to consider when reopening the economy“, an Indianapolis Business Journal (IBJ) Forefront column, was published April 10, 2020.

“Beating this pandemic will take time,” they write. “It will not be easy, but we can and will succeed. Unfortunately, there are no short-cuts, only tempting detours that risk prolonging this painful journey. To arrive safely, we will need good data-driven decision making, continued collaboration, and steadfast determination.”

The two clinician-researchers call for data-driven development of a rational plan for gradual easing of social-distancing, sheltering at home, and temporary closure of nonessential businesses (collectively called “nonpharmaceutical interventions”) as communities begin the slow return to a healthy and prosperous life.

They highlight five areas critical for consideration as the state and nation move toward terminating personal isolation and business closure mandates, hopefully in the not-too-distant future. These are: (1) designation of principles for winding down these nonpharmaceutical interventions; (2) tracking and testing of the virus, as well as maintaining an early-warning system to detect new outbreaks; (3) gaining a more nuanced understanding of the disease; (4) treatment and vaccine development through expansion of clinical trials; (5) learning from the experiences of other nations.

Overcoming this pandemic will take time and not be easy, but Dr. Embí and Dr. Grannis observe that success will require good data-driven decision-making along with continued collaboration and steadfast determination.

Read the IBJ Forefront column.

Related News

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,